首页> 美国卫生研究院文献>In Vivo >The Impact of Peripheral Eosinophil Counts and Eosinophil to Lymphocyte Ratio (ELR) in the Clinical Course of COVID-19 Patients: A Retrospective Study
【2h】

The Impact of Peripheral Eosinophil Counts and Eosinophil to Lymphocyte Ratio (ELR) in the Clinical Course of COVID-19 Patients: A Retrospective Study

机译:Covid-19患者临床过程中外周血嗜酸铈核细胞计数和嗜酸性粒细胞对淋巴细胞比(ELR)的影响:回顾性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Background/Aim: Eosinophils are blood cells responsible for response against parasites and allergens. Εοsinophil to lymphocyte ratio (ELR) is a biomarker for inflammatory conditions. Our aim was to evaluate the role of eosinophils and ELR in COVID-19 patients. Patients and Methods: The study included 96 patients hospitalized with COVID-19. They were classified into moderate to severe cases and critical cases. Eosinophils and ELR were determined in both groups, in patients that died or survived and were correlated to duration of hospitalization. Results: There was a statistically significant decrease in eosinophils and ELR between patients that died and patients that survived (p<0.05), and in mean values of the two biomarkers (p<0.05 for eosinophils and p<0.05 for ELR) between patients hospitalized for more or less than 15 days among those with moderate to severe disease. Conclusion: Lower eosinophil counts and ERL could probably predict worse outcome in COVID-19 patients.
机译:背景/目的:嗜酸性粒细胞是对寄生虫和过敏原的反应负责的血细胞。对淋巴细胞比率(ELR)的εOOCOOPOOCOOCHI是炎症病症的生物标志物。我们的目标是评估嗜酸性粒细胞和ELR在Covid-19患者中的作用。患者和方法:该研究包括96名与Covid-19住院的患者。它们分为中度至严重的病例和危急案件。在两组中,嗜酸性粒细胞和ELR在死亡或存活的患者中确定,并与住院期间相关。结果:患有患者的嗜酸性粒细胞和患者的患者在患者住院期间患者(P <0.05)的患者和患者的患者之间存在统计学上显着的降低(P <0.05),患者之间的两种生物标志物的平均值(P <0.05,为ELR的P <0.05)在那些中度至严重疾病中的人中或多或少15天。结论:低嗜酸性粒细胞计数和ERL可能预测Covid-19患者的更差。

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号